Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Clemente, Roque"'
Autor:
David Fiorella, Christine M Denice, Clemente Roque, Henry H. Woo, Yu Deuerling-Zheng, Aquilla S Turk, Adrian T. Parker, Jared Dunkin, Marlene Baumeister, Imran Chaudry, Raymond D Turner, Marily Sarmiento
Publikováno v:
Journal of Neurointerventional Surgery
Purpose Newer flat panel angiographic detector (FD) systems have the capability to generate parenchymal blood volume (PBV) maps. The ability to generate these maps in the angiographic suite has the potential to markedly expedite the triage and treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10949949f3cd3130da3efb5d0ac3f2b
https://doi.org/10.1136/neurintsurg-2013-010840
https://doi.org/10.1136/neurintsurg-2013-010840
Autor:
Elizabeth M. Bosler, Dushyantha Jayaweera, Jean-Louis Vildé, Jack S. Remington, Philippe Morlat, Richard Hafner, Janet Andersen, Catherine Leport, Natasa Rajicic, Benjamin J. Luft, Keith Chirgwin, Vincent McAuliffe, Clemente Roque
Publikováno v:
Clinical Infectious Diseases. 34:1243-1250
In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5965cf5ef9470dc47d1ef49fc8958c2
https://doi.org/10.1086/339551
https://doi.org/10.1086/339551
Publikováno v:
Stroke. 32:2774-2781
Background and Purpose — Diffusion-weighted MRI (DWI) is highly sensitive to early cerebral ischemia, but its dependence on lesion location, acuity, and etiology remains unknown. Furthermore, although a marked perfusion-weighted MRI (PWI)-DWI misma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3f1b8744f53ea13d1330542ed39665
https://doi.org/10.1161/hs1201.099634
https://doi.org/10.1161/hs1201.099634
Autor:
Patricia Roche, James Manzione, Clemente Roque, Arafat Tfayli, Stefan Madajewicz, Maisie L. Shindo
Publikováno v:
Seminars in Interventional Radiology. 15:365-371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4859ecdbe002ff2c4274759159560517
https://doi.org/10.1055/s-2008-1057029
https://doi.org/10.1055/s-2008-1057029
Publikováno v:
Stroke. 43
Background and Objective: Craniocervical arterial dissection (CCAD) is believed to have a relatively benign natural history & generally is managed with anticoagulation or antiplatelet therapy.The purpose of this study is to identify whether clinicora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01deeb370b9358ce5ff9b0e3f22f3f81
https://doi.org/10.1161/str.43.suppl_1.a3626
https://doi.org/10.1161/str.43.suppl_1.a3626
Autor:
Ronald Beaton, Stephanie Fertman, Afif Iliya, Mehender Pampati, Raphael P. Davis, Naveed Chowhan, Orlando Alvarez, Allen G. Meek, Stefan Madajewicz, Clemente Roque, George W. Tyson
Publikováno v:
Cancer. 67:2844-2849
Chemotherapy for tumors of the central nervous system has a limited efficacy presumably because of restricted blood-brain barrier permeability. The advantage of regional intra-arterial administration of anticancer drugs is an increased uptake during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d9617358c85e9cda51a1b7f6220c4b2
https://doi.org/10.1002/1097-0142(19910601)67:11<2844::aid-cncr2820671123>3.0.co
https://doi.org/10.1002/1097-0142(19910601)67:11<2844::aid-cncr2820671123>3.0.co
Autor:
Patricia Melville, Patricia Roche, William S. MacAllister, Robert G. Peyster, Tina M. Morgan, Clemente Roque, Wei Huang, Luminita A. Tudorica, Xin Li, William F. Scherl, Lauren B. Krupp, Lihong Li, Christopher Christodoulou, Zhengrong Liang
Publikováno v:
Neurology. 60(11)
Objective: To relate neuropsychological performance to measures of cerebral injury in persons with MS selected for cognitive impairment. Methods: Participants were 37 individuals with relapsing–remitting (59.5%) and secondary progressive (40.5%) MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5fe75caa581e4b2d8b9f300f3ee9df
https://pubmed.ncbi.nlm.nih.gov/12796533
https://pubmed.ncbi.nlm.nih.gov/12796533
Autor:
Keith, Chirgwin, Richard, Hafner, Catherine, Leport, Jack, Remington, Janet, Andersen, Elizabeth M, Bosler, Clemente, Roque, Natasa, Rajicic, Vincent, McAuliffe, Philippe, Morlat, D T, Jayaweera, Jean-Louis, Vilde, Benjamin J, Luft
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 34(9)
In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ff3e8033dde8771666ff9363c5f9e70
https://pubmed.ncbi.nlm.nih.gov/11941551
https://pubmed.ncbi.nlm.nih.gov/11941551
Autor:
Elizabeth M. Bosler, Dushyantha Jayaweera, Benjamin J. Luft, Jeffrey M. Jacobson, Carol Harris, Jeanne Holden-Wiltse, Charles Farthing, Clemente Roque, Jack S. Remington, Richard Hafner
Publikováno v:
AIDS (London, England). 15(5)
Objective: To assess the safety, tolerance and activity of increasing doses of azithromycin in combination with pyrimethamine for the treatment of toxoplasmic encephalitis (TE) in patients with AIDS. Design: A phase I/II dose-escalation study of oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3576e2c852f5efcb69e68abb216c27
https://pubmed.ncbi.nlm.nih.gov/11316995
https://pubmed.ncbi.nlm.nih.gov/11316995
Autor:
Stefan Madajewicz, Alex Braun, Harold Atkins, Affif Iliya, Patricia Roche, Arafat Tfayli, Allen Meek, Magdy Shady, Naveed Chowhan, Corazon Cabahug, Raphael Davis, Walter Wolf, Clemente Roque, James Manzione, N P Patricia Hentschel
Publikováno v:
Cancer. 88(10)
BACKGROUND High grade astrocytomas account for approximately 40% of all primary brain tumors. The median survival is approximately 8–10 months for patients with glioblastoma multiforme and 36 months for patients with anaplastic astrocytoma. The res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf99d9b1cb1619942dc81fc5326558e2
https://pubmed.ncbi.nlm.nih.gov/10820358
https://pubmed.ncbi.nlm.nih.gov/10820358